Home » Topics » Regulatory » Patents

Patents
RSS

Inhibitors of the formation of AGTs described by Alteon

April 5, 1999

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

Merck & Co. presents new macrolide immunosuppressants

April 1, 1999

Dopaminergic agents for anxiety, depression and Parkinson's disease disclosed by ADIR

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

Multiple pharmacological effects reported by Egis for new AMPA receptor antagonists

March 31, 1999

Ono discloses PPARgamma modulators for metabolic disorders

March 31, 1999

Nonpeptide tachykinin antagonists: preparation and use described by Lilly

March 31, 1999

Postmenopausal syndrome continues as focus of R&D at Lilly

March 31, 1999

Lilly's new agents for lipid disorders act by increasing HDL cholesterol levels

March 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...